Liuweiwuling Tablet relieves the inflammatory transformation of hepatocellular carcinoma by inhibiting the PI3K/AKT/NF-κB signaling pathway.
Chen Y, Song Z, Hou X, Liu J, Zheng C, Zhao X, Lv G, Li J, Xiu Y, Shi W, Zhao J, Yang H, Wang Y, Zhao J, Zhan X, Niu M, Zou W, Bai Z, Xiao X.
Chen Y, et al. Among authors: zheng c.
J Ethnopharmacol. 2024 Mar 1;321:117406. doi: 10.1016/j.jep.2023.117406. Epub 2023 Nov 11.
J Ethnopharmacol. 2024.
PMID: 37952733